1 in 5 cancer trials fail to complete
I came across this in a newsletter I subscribe to by e-mail. It is staggering that 20% of cancer clinical trials fail to complete, and only 1% of those is due to the efficacy of the drug or some other adverse event. When I think how difficult it seems to be to get a trial up and running this scale of failure is … appalling. What a waste of time, effort and money; even though one reason for a trial to fail to complete is because funding is withdrawn.
Why is this happening? Is there some sort of lack of planning that is causing this? When you think how many people are hoping for a treatment, or a cure, for their form of cancer it is heart breaking to find out that there is such a high rate of failure. It is even more so when you take into account that it seems that quite a few trials don’t have a really sound basis and would seem to be pitting the full efficacy of a new drug against low doses of the present standard treatment. Just watch this to hear about some of the things that the drug companies allegedly get up to. http://www.youtube.com/watch?v=ZqKY6Gr6D3Q
Trials should focus on the benefit to the patient and be done with this in mind, and not the benefit to the drug company if they can get it approved. It should be an honest comparison between similar drugs so that the one which is genuinely better becomes clear in the results. We need HOPE that in the future there will be more choices and treatment options, not just tantalizing headlines about new breakthroughs which never go anywhere.